Last checked at 
Uniphar PLC - Dublin-based healthcare services firm - Says it remains confident in delivering on current year expectations and that medium term organic growth targets at a divisional level remain unchanged. Posts organic gross profit growth of 11% for the half year period ended June 30. Growth is driven by continued outperformance in the Commercial & Clinical division and by strong performances in the Product Access and Supply Chain & Retail divisions, it says.
Mergers and acquisitions will "continue to play an important part in Uniphar's growth strategy" and the business will monitor its active pipeline of acquisition opportunities, the company notes.
"Our trading update reflects a strong start to the year with the group delivering double-digit organic gross profit growth. I am pleased to report that all our divisions are performing well, with the outperformance in Commercial & Clinical representing a particularly strong result," comments Chief Executive Ger Rabbette.
Current stock price: 329.00 pence, up 4.4% Tuesday afternoon
Year-to-date change: up 49%
By Will Paige; willpaige@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
